Date updated:05-16-2008
mostly biological/pharmacuetical companies that could possibly make it big

-
AVII
Avi Biopharma - $1.44
- -3.36%
- $1.46
gene therapy

-
ADLS
Adls - $0.00
- N/A
- $N/A
pharmacutical company that is in the finishing stages of a drug cethromycin and planning on partnering with a larger company upon completion

-
BPUR
Bpur - $0.00
- N/A
- $N/A
blood substitute

-
CTIC
Cell Therapeutics - $0.9882
- -3.12%
- $0.9801
Zevalin - cancer and cell therapy

-
DSCO
Discovery Laborat - $0.81
- +2.53%
- $0.78
Surfaxin, a drug that is in the process of being approved to prevent respiratory death syndrome (RDS) in premature infants

-
GNVC
Genvec - $0.8798
- 0.00%
- $N/A
received 600,000$ grant from NIH to work on vaccince for pediatric respiratory virus. also working on vaccines for herpes and malaria. has a drug in clinical trials for pancreatic cancer and data should be seen by the end of the year.

-
JBLU
Jetblue Airways C - $5.24
- +8.49%
- $4.82
sweetass

-
BWEN
Broadwind Energy - $5.72
- 0.00%
- $N/A
wind power
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the largest % gainers from Nov. 2, 2009. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
Analyst Upgrades for Nov. 2, 2009. Read more here. more













Comments not available